DexCom Company Profile (NASDAQ:DXCM)

About DexCom (NASDAQ:DXCM)

DexCom logoDexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:DXCM
  • CUSIP: 25213110
  • Web: www.dexcom.com
Capitalization:
  • Market Cap: $6.04588 billion
  • Outstanding Shares: 86,369,000
Average Prices:
  • 50 Day Moving Avg: $72.79
  • 200 Day Moving Avg: $75.75
  • 52 Week Range: $57.68 - $96.38
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 982.14
  • P/E Growth: -2.74
Sales & Book Value:
  • Annual Revenue: $599.4 million
  • Price / Sales: 9.91
  • Book Value: $3.22 per share
  • Price / Book: 21.35
Profitability:
  • EBIDTA: ($69,800,000.00)
  • Net Margins: -14.70%
  • Return on Equity: -32.94%
  • Return on Assets: -22.52%
Debt:
  • Current Ratio: 1.92%
  • Quick Ratio: 1.65%
Misc:
  • Average Volume: 1.18 million shs.
  • Beta: 0.51
  • Short Ratio: 9.58
 
Frequently Asked Questions for DexCom (NASDAQ:DXCM)

What is DexCom's stock symbol?

DexCom trades on the NASDAQ under the ticker symbol "DXCM."

How were DexCom's earnings last quarter?

DexCom, Inc. (NASDAQ:DXCM) posted its earnings results on Tuesday, May, 2nd. The company reported ($0.49) EPS for the quarter, topping analysts' consensus estimates of ($0.55) by $0.06. The company had revenue of $142.30 million for the quarter, compared to the consensus estimate of $143.94 million. DexCom had a negative return on equity of 32.94% and a negative net margin of 14.70%. View DexCom's Earnings History.

When will DexCom make its next earnings announcement?

DexCom is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for DexCom.

Where is DexCom's stock going? Where will DexCom's stock price be in 2017?

18 brokers have issued 1 year target prices for DexCom's shares. Their predictions range from $66.00 to $105.00. On average, they expect DexCom's stock price to reach $89.47 in the next year. View Analyst Ratings for DexCom.

What are analysts saying about DexCom stock?

Here are some recent quotes from research analysts about DexCom stock:

  • 1. According to Zacks Investment Research, "In the past one year, DexCom has underperformed the broader industry in terms of price. Furthermore, a disappointing estimate revision trend indicates looming concerns ahead. DexCom reported narrower-than-expected loss in the first quarter. We believe the company’s margins will continue to be under pressure in the coming quarters owing to high product development costs and rising expenditures on research & development. Specifically, the company is expected to have lower margins on transmitter sales (in spite of the cost reduction initiatives). Additionally, cutthroat competition in the market for blood glucose monitoring devices is a major headwind. On the positive side, the glucose monitoring market represents significant commercial opportunity for DexCom. The company has also signed collaborative agreements with several companies, which should not only bring in cash but also help expand its product portfolio." (7/18/2017)
  • 2. Jefferies Group LLC analysts commented, "DXCM reported 4Q sales $3mn ahead of its pre-announcement. Guidance for 2017 remained +25-30% ($710-740mn); importantly, this considers competitive entries by MDT (670G) and ABT (Libre), but does not factor in any contribution from DXCM patients covered by Medicare. With this low bar set for 2017, the next-gen G6 and the Verily Type 2 system coming in 2018, DXCM remains well positioned to succeed in an evolving diabetes landscape. The stock remains a top idea." (3/1/2017)
  • 3. BTIG Research analysts commented, "Most Important; But The Report Was Not Clean; Buy As we previewed, revenue of $137.3M was in-line with our estimate and well above the street. We think this is most important. GMs disappointed and the $10M guidance raise was likely less than some hoped. With the stock having run from the $60s to the $90s, it is not surprising to see it pull back to the mid $80s afterhours. We would opportunistically buy shares on dips and would become aggressive around $80.   Top-line growth continues to beat expectations, thesis remains the same though in the $80s, upside has moderated. Having crushed both Q1 and Q2 sales expectations, we see DXCM as meeting our growth thesis. We believe some expected a raise beyond the new $550-$575M FY16 guidance. While this may pressure shares tomorrow we note during Q&A, mgmt did discuss how they would be pleased to come in above this when asked about $575-$600M. We model above guidance with $581M for Fy16." (8/4/2016)

Who are some of DexCom's key competitors?

Who are DexCom's key executives?

DexCom's management team includes the folowing people:

  • Terrance H. Gregg, Executive Chairman of the Board
  • Kevin R. Sayer, President, Chief Executive Officer, Director
  • Kevin M. Sun, Interim Chief Financial Officer
  • Donald Abbey, Executive Vice President, Quality and Information Technology
  • Andrew K. Balo, Executive Vice President - Clinical, Regulatory and Quality
  • Richard B. Doubleday, Executive Vice President, Chief Commercial Officer
  • Steven R. Pacelli, Executive Vice President - Strategy and Corporate Development
  • Heather Ace, Senior Vice President, Human Resources
  • Jake Leach, Senior Vice President of Research and Development
  • Jeffrey C. Moy, Senior Vice President - Operations

Who owns DexCom stock?

DexCom's stock is owned by many different of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (0.37%), Rothschild Capital Partners LLC (0.07%), Chevy Chase Trust Holdings Inc. (0.05%), Patten & Patten Inc. TN (0.05%), Bank of Montreal Can (0.04%) and Sit Investment Associates Inc. (0.03%). Company insiders that own DexCom stock include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven R Altman, Steven Robert Pacelli and Terrance H Gregg. View Institutional Ownership Trends for DexCom.

Who sold DexCom stock? Who is selling DexCom stock?

DexCom's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Shell Asset Management Co., OLD National Bancorp IN, Bremer Trust National Association, Patten & Patten Inc. TN, Sumitomo Mitsui Asset Management Company LTD and BB&T Corp. Company insiders that have sold DexCom stock in the last year include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven Robert Pacelli and Terrance H Gregg. View Insider Buying and Selling for DexCom.

Who bought DexCom stock? Who is buying DexCom stock?

DexCom's stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Bank of Montreal Can, Handelsbanken Fonder AB, Mn Services Vermogensbeheer B.V., US Bancorp DE, Sit Investment Associates Inc., Fox Run Management L.L.C. and Chevy Chase Trust Holdings Inc.. View Insider Buying and Selling for DexCom.

How do I buy DexCom stock?

Shares of DexCom can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DexCom's stock price today?

One share of DexCom stock can currently be purchased for approximately $68.75.


MarketBeat Community Rating for DexCom (NASDAQ DXCM)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  476 (Vote Outperform)
Underperform Votes:  211 (Vote Underperform)
Total Votes:  687
MarketBeat's community ratings are surveys of what our community members think about DexCom and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DexCom (NASDAQ:DXCM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $89.47 (30.13% upside)

Analysts' Ratings History for DexCom (NASDAQ:DXCM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Cowen and CompanyReiterated RatingBuy$90.00MediumView Rating Details
7/13/2017BMO Capital MarketsReiterated RatingBuy$105.00MediumView Rating Details
7/12/2017Piper Jaffray CompaniesReiterated RatingBuy$78.00LowView Rating Details
6/7/2017Canaccord GenuityReiterated RatingBuy$90.00LowView Rating Details
5/9/2017Jefferies Group LLCLower Price TargetBuy$91.00LowView Rating Details
5/7/2017B. RileyReiterated RatingBuy$95.00HighView Rating Details
5/3/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$98.00HighView Rating Details
5/3/2017BTIG ResearchDowngradeBuy -> NeutralHighView Rating Details
4/27/2017William BlairReiterated RatingOutperformLowView Rating Details
4/4/2017Royal Bank Of CanadaReiterated RatingOutperform$87.00MediumView Rating Details
3/1/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
2/16/2017Robert W. BairdReiterated RatingNeutral$79.00N/AView Rating Details
1/11/2017WedbushReiterated RatingOutperform$85.00N/AView Rating Details
1/3/2017Morgan StanleyDowngradeOverweight -> Equal Weight$87.00 -> $66.00N/AView Rating Details
11/3/2016Leerink SwannReiterated RatingOutperform$115.00 -> $100.00N/AView Rating Details
9/16/2016DesjardinsUpgradeHold -> BuyN/AView Rating Details
8/3/2016J P Morgan Chase & CoReiterated RatingBuy$100.00N/AView Rating Details
8/3/2016Benchmark Co.Lower Price TargetBuy$106.00 -> $86.00N/AView Rating Details
7/15/2016Deutsche Bank AGBoost Price TargetBuy$90.00 -> $98.00N/AView Rating Details
2/26/2016Raymond James Financial, Inc.Lower Price TargetOutperform$100.00 -> $81.00N/AView Rating Details
10/15/2015Sterne Agee CRTUpgradeNeutral -> Buy$90.00N/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for DexCom (NASDAQ:DXCM)
Earnings by Quarter for DexCom (NASDAQ:DXCM)
Earnings History by Quarter for DexCom (NASDAQ DXCM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017($0.21)N/AView Earnings Details
5/2/2017Q1 2017($0.55)($0.49)$143.94 million$142.30 millionViewListenView Earnings Details
2/28/2017Q416($0.10)($0.09)$167.51 million$171.20 millionViewListenView Earnings Details
11/1/2016Q316($0.14)($0.22)$146.09 million$148.60 millionViewN/AView Earnings Details
8/2/2016Q216($0.12)($0.24)$132.48 million$137.30 millionViewN/AView Earnings Details
4/27/2016Q116($0.20)($0.23)$110.37 million$116.20 millionViewListenView Earnings Details
2/23/2016Q415$0.01$0.02$122.93 million$130.80 millionViewListenView Earnings Details
11/4/2015Q315($0.01)($0.07)$97.47 million$105.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.03)($0.05)$84.74 million$93.20 millionViewN/AView Earnings Details
4/29/2015Q115($0.11)($0.17)$71.32 million$72.80 millionViewN/AView Earnings Details
2/25/2015Q414($0.03)$0.02$79.65 million$84.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.05)($0.08)$60.20 million$67.90 millionViewN/AView Earnings Details
8/6/2014Q214($0.10)($0.10)$52.45 million$58.80 millionViewListenView Earnings Details
5/1/2014Q114($0.08)($0.17)$44.15 million$47.10 millionViewListenView Earnings Details
2/20/2014Q413($0.07)($0.04)$48.53 million$51.30 millionViewListenView Earnings Details
11/6/2013Q313($0.13)($0.09)$35.90 million$42.90 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.16)($0.14)$31.14 million$35.80 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.17)($0.16)$28.26 million$29.60 millionViewN/AView Earnings Details
2/21/2013Q4 2012($0.15)($0.12)$31.09 million$33.30 millionViewN/AView Earnings Details
11/1/2012Q312($0.22)($0.25)$23.14 million$23.10 millionViewN/AView Earnings Details
8/6/2012($0.20)($0.21)ViewN/AView Earnings Details
5/2/2012($0.19)($0.21)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/2/2011($0.15)($0.20)ViewN/AView Earnings Details
8/3/2011($0.11)($0.11)ViewN/AView Earnings Details
5/3/2011($0.19)($0.19)ViewN/AView Earnings Details
3/3/2011($0.19)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DexCom (NASDAQ:DXCM)
2017 EPS Consensus Estimate: ($0.68)
2018 EPS Consensus Estimate: $0.12
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20178($0.68)($0.19)($0.53)
Q2 20178($0.28)($0.12)($0.18)
Q3 20178($0.15)$0.06($0.06)
Q4 20178($0.08)$0.31$0.10
Q1 20184($0.21)($0.01)($0.13)
Q2 20184($0.04)$0.05$0.01
Q3 20184$0.01$0.15$0.07
Q4 20184$0.09$0.28$0.17
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DexCom (NASDAQ:DXCM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for DexCom (NASDAQ:DXCM)
Insider Ownership Percentage: 1.70%
Insider Trades by Quarter for DexCom (NASDAQ:DXCM)
Institutional Ownership by Quarter for DexCom (NASDAQ:DXCM)
Insider Trades by Quarter for DexCom (NASDAQ:DXCM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/24/2017Steven Robert PacelliEVPSell1,450$69.47$100,731.50View SEC Filing  
7/12/2017Kevin R. SayerCEOSell6,000$71.86$431,160.00View SEC Filing  
7/10/2017Andrew K. BaloEVPSell3,200$71.55$228,960.00View SEC Filing  
6/23/2017Steven Robert PacelliEVPSell1,450$78.19$113,375.50View SEC Filing  
6/12/2017Andrew K. BaloEVPSell3,200$69.06$220,992.00View SEC Filing  
6/12/2017Kevin R. SayerCEOSell6,000$69.07$414,420.00View SEC Filing  
5/23/2017Richard DoubledayEVPSell3,182$68.29$217,298.78View SEC Filing  
5/17/2017Kevin R SayerCEOSell8,649$68.39$591,505.11View SEC Filing  
5/10/2017Andrew K. BaloEVPSell3,200$71.93$230,176.00View SEC Filing  
4/24/2017Richard DoubledayEVPSell3,182$75.78$241,131.96View SEC Filing  
4/20/2017Terrance H GreggInsiderSell15,000$74.10$1,111,500.00View SEC Filing  
4/17/2017Kevin R SayerCEOSell10,000$75.63$756,300.00View SEC Filing  
4/10/2017Andrew K. BaloEVPSell3,200$78.19$250,208.00View SEC Filing  
3/23/2017Richard DoubledayEVPSell3,182$76.38$243,041.16View SEC Filing  
3/22/2017Jess RoperCFOSell2,000$75.97$151,940.00View SEC Filing  
3/17/2017Kevin R SayerCEOSell10,000$77.82$778,200.00View SEC Filing  
3/14/2017Jacob Steven LeachSVPSell21,317$77.63$1,654,838.71View SEC Filing  
3/13/2017Jorge A. ValdesInsiderSell14,400$77.74$1,119,456.00View SEC Filing  
3/9/2017John ListerInsiderSell3,000$77.67$233,010.00View SEC Filing  
3/6/2017Jay S SkylerDirectorSell31,890$78.13$2,491,565.70View SEC Filing  
2/23/2017Richard DoubledayEVPSell3,182$78.42$249,532.44View SEC Filing  
1/23/2017Richard DoubledayEVPSell3,182$79.50$252,969.00View SEC Filing  
1/18/2017Jess RoperCFOSell3,012$85.01$256,050.12View SEC Filing  
1/17/2017Kevin R SayerCEOSell10,000$85.94$859,400.00View SEC Filing  
1/13/2017John ListerInsiderSell15,000$79.36$1,190,400.00View SEC Filing  
1/10/2017Andrew K BaloEVPSell3,200$62.86$201,152.00View SEC Filing  
1/9/2017Jorge A ValdesInsiderSell10,900$63.02$686,918.00View SEC Filing  
12/23/2016Richard DoubledayEVPSell3,182$62.17$197,824.94View SEC Filing  
12/9/2016Jorge A ValdesInsiderSell10,000$64.81$648,100.00View SEC Filing  
10/24/2016Jess RoperCFOSell2,471$80.75$199,533.25View SEC Filing  
10/24/2016Steven Robert PacelliEVPSell10,300$81.95$844,085.00View SEC Filing  
10/19/2016Andrew K. BaloEVPSell4,997$82.31$411,303.07View SEC Filing  
10/14/2016Kevin R. SayerCEOSell7,000$81.87$573,090.00View SEC Filing  
10/10/2016John ListerInsiderSell3,560$84.41$300,499.60View SEC Filing  
10/5/2016Andrew K. BaloEVPSell5,000$82.55$412,750.00View SEC Filing  
9/23/2016Richard DoubledayEVPSell3,182$93.97$299,012.54View SEC Filing  
9/22/2016Jess RoperCFOSell2,470$93.99$232,155.30View SEC Filing  
9/21/2016Andrew K. BaloEVPSell5,000$92.87$464,350.00View SEC Filing  
9/14/2016Kevin R. SayerCEOSell7,000$91.79$642,530.00View SEC Filing  
9/12/2016Jay S SkylerDirectorSell10,000$93.00$930,000.00View SEC Filing  
9/12/2016Jorge A ValdesInsiderSell19,071$93.07$1,774,937.97View SEC Filing  
9/9/2016Jay S SkylerDirectorSell25,000$94.07$2,351,750.00View SEC Filing  
9/9/2016John ListerInsiderSell3,560$93.65$333,394.00View SEC Filing  
9/8/2016Terrance H GreggInsiderSell10,740$95.29$1,023,414.60View SEC Filing  
9/7/2016Andrew K BaloEVPSell4,999$94.45$472,155.55View SEC Filing  
9/7/2016Mark G. FolettaDirectorSell1,800$94.63$170,334.00View SEC Filing  
9/1/2016Jonathan T. Md LordDirectorSell10,000$91.50$915,000.00View SEC Filing  
8/30/2016Terrance H GreggInsiderSell10,000$92.14$921,400.00View SEC Filing  
8/24/2016Andrew K BaloEVPSell5,000$91.72$458,600.00View SEC Filing  
8/24/2016Terrance H GreggInsiderSell10,000$92.72$927,200.00View SEC Filing  
8/23/2016Steven Robert PacelliEVPSell10,300$90.74$934,622.00View SEC Filing  
8/23/2016Terrance H GreggChairmanSell10,000$91.11$911,100.00View SEC Filing  
8/22/2016Terrance H GreggChairmanSell10,000$90.51$905,100.00View SEC Filing  
8/19/2016Jay S SkylerDirectorSell25,000$90.77$2,269,250.00View SEC Filing  
8/19/2016Terrance H GreggInsiderSell40,000$90.70$3,628,000.00View SEC Filing  
8/15/2016Kevin R. SayerCEOSell7,000$90.78$635,460.00View SEC Filing  
8/15/2016Terrance H GreggChairmanSell14,942$91.01$1,359,871.42View SEC Filing  
8/12/2016Jonathan T. Md LordDirectorSell10,000$90.64$906,400.00View SEC Filing  
8/11/2016Terrance H GreggInsiderSell10,900$91.03$992,227.00View SEC Filing  
8/10/2016Andrew K BaloEVPSell5,000$90.26$451,300.00View SEC Filing  
8/9/2016Jorge A ValdesInsiderSell32,000$91.06$2,913,920.00View SEC Filing  
8/9/2016Kevin R SayerCEOSell20,000$90.98$1,819,600.00View SEC Filing  
8/8/2016Barbara KahnDirectorSell6,000$90.52$543,120.00View SEC Filing  
8/5/2016Terrance H. GreggInsiderSell35,000$79.81$2,793,350.00View SEC Filing  
8/1/2016Jeffrey MoySVPSell15,000$92.33$1,384,950.00View SEC Filing  
7/27/2016Andrew K BaloEVPSell5,000$88.14$440,700.00View SEC Filing  
7/25/2016Richard DoubledayEVPSell3,182$87.31$277,820.42View SEC Filing  
7/22/2016Jeffrey MoySVPSell10,000$88.48$884,800.00View SEC Filing  
7/19/2016Jeffrey MoySVPSell12,843$83.78$1,075,986.54View SEC Filing  
7/13/2016Andrew K BaloEVPSell5,000$80.12$400,600.00View SEC Filing  
7/13/2016Kevin R. SayerCEOSell7,000$79.92$559,440.00View SEC Filing  
7/11/2016Jorge A ValdesInsiderSell32,000$79.36$2,539,520.00View SEC Filing  
6/29/2016Andrew K BaloEVPSell5,000$78.10$390,500.00View SEC Filing  
6/29/2016Jeffrey MoySVPSell4,557$80.00$364,560.00View SEC Filing  
6/23/2016Steven Robert PacelliEVPSell10,300$77.40$797,220.00View SEC Filing  
6/20/2016Andrew K BaloEVPSell55,000$75.00$4,125,000.00View SEC Filing  
6/20/2016Jeffrey MoySVPSell7,209$77.00$555,093.00View SEC Filing  
6/20/2016Kevin R. SayerCEOSell35,000$75.00$2,625,000.00View SEC Filing  
6/9/2016Jeffrey MoySVPSell6,910$74.00$511,340.00View SEC Filing  
6/9/2016John ListerInsiderSell3,560$73.27$260,841.20View SEC Filing  
6/8/2016Jeffrey MoySVPSell6,866$71.00$487,486.00View SEC Filing  
6/8/2016Jorge A ValdesInsiderSell18,038$72.06$1,299,818.28View SEC Filing  
6/8/2016Steven Robert PacelliEVPSell18,239$70.88$1,292,780.32View SEC Filing  
6/7/2016Jess RoperCFOSell3,471$69.00$239,499.00View SEC Filing  
5/23/2016Richard DoubledayEVPSell1,674$63.59$106,449.66View SEC Filing  
5/18/2016Jorge A ValdesInsiderSell20,000$61.75$1,235,000.00View SEC Filing  
5/16/2016Terrance H GreggChairmanSell20,000$62.72$1,254,400.00View SEC Filing  
5/12/2016Barbara KahnDirectorSell3,000$60.72$182,160.00View SEC Filing  
5/11/2016Terrance H GreggChairmanSell8,600$64.32$553,152.00View SEC Filing  
5/9/2016John ListerInsiderSell3,560$62.50$222,500.00View SEC Filing  
5/9/2016Terrance H GreggChairmanSell12,168$62.42$759,526.56View SEC Filing  
4/27/2016Jorge A ValdesInsiderSell10,000$70.00$700,000.00View SEC Filing  
4/27/2016Steven Robert PacelliEVPSell2,361$70.39$166,190.79View SEC Filing  
4/25/2016Jess RoperCFOSell3,471$69.00$239,499.00View SEC Filing  
4/25/2016Richard DoubledayEVPSell1,666$69.15$115,203.90View SEC Filing  
4/12/2016John ListerInsiderSell3,704$65.78$243,649.12View SEC Filing  
4/11/2016Terrance H GreggChairmanSell2,169$68.00$147,492.00View SEC Filing  
4/4/2016Jorge A ValdesInsiderSell20,000$70.08$1,401,600.00View SEC Filing  
4/4/2016Steven Robert PacelliEVPSell20,600$70.62$1,454,772.00View SEC Filing  
3/31/2016Jess RoperCFOSell3,470$69.00$239,430.00View SEC Filing  
3/23/2016Richard DoubledayEVPSell1,666$61.76$102,892.16View SEC Filing  
3/22/2016Terrance H GreggChairmanSell25,000$59.51$1,487,750.00View SEC Filing  
3/14/2016John ListerInsiderSell3,560$63.75$226,950.00View SEC Filing  
3/7/2016Barbara KahnDirectorSell5,000$67.04$335,200.00View SEC Filing  
2/23/2016Richard DoubledayEVPSell1,666$64.36$107,223.76View SEC Filing  
2/18/2016John ListerVPSell3,560$62.50$222,500.00View SEC Filing  
1/25/2016Steven Robert PacelliEVPSell10,300$73.24$754,372.00View SEC Filing  
1/22/2016Jess RoperCFOSell3,518$72.97$256,708.46View SEC Filing  
1/20/2016Kevin R SayerCEOSell7,000$75.00$525,000.00View SEC Filing  
1/12/2016Jorge A ValdesInsiderSell5,610$80.16$449,697.60View SEC Filing  
1/11/2016Jorge A ValdesInsiderSell1,641$78.43$128,703.63View SEC Filing  
1/8/2016John ListerVPSell3,560$82.57$293,949.20View SEC Filing  
12/23/2015Richard DoubledayEVPSell1,666$82.22$136,978.52View SEC Filing  
12/22/2015Jess RoperCFOSell3,417$81.19$277,426.23View SEC Filing  
12/17/2015Andrew K. BaloEVPSell7,500$82.52$618,900.00View SEC Filing  
12/14/2015John ListerVPSell3,560$82.50$293,700.00View SEC Filing  
12/9/2015Jorge A. ValdesinsiderSell10,000$85.74$857,400.00View SEC Filing  
12/8/2015John ListerVPSell2,476$87.16$215,808.16View SEC Filing  
12/4/2015Terrance H. GreggChairmanSell10,000$86.79$867,900.00View SEC Filing  
12/3/2015Andrew K. BaloEVPSell7,500$86.37$647,775.00View SEC Filing  
12/2/2015Terrance H. GreggChairmanSell10,000$87.05$870,500.00View SEC Filing  
11/30/2015Terrance H. GreggChairmanSell5,000$86.50$432,500.00View SEC Filing  
11/25/2015Andrew K. BaloEVPSell7,500$87.49$656,175.00View SEC Filing  
11/25/2015Terrance H. GreggChairmanSell15,000$87.53$1,312,950.00View SEC Filing  
11/24/2015Andrew K. BaloEVPSell10,000$86.43$864,300.00View SEC Filing  
11/24/2015Terrance H. GreggChairmanSell15,497$86.54$1,341,110.38View SEC Filing  
11/23/2015Richard DoubledayEVPSell1,666$85.85$143,026.10View SEC Filing  
11/20/2015Terrance H. GreggChairmanSell22,003$86.48$1,902,819.44View SEC Filing  
11/18/2015Jess RoperCFOSell7,000$84.15$589,050.00View SEC Filing  
11/16/2015Terrance H. GreggChairmanSell20,000$83.89$1,677,800.00View SEC Filing  
11/12/2015Jess RoperCFOSell20,000$84.07$1,681,400.00View SEC Filing  
11/11/2015Andrew K. BaloEVPSell7,500$84.50$633,750.00View SEC Filing  
10/23/2015Richard DoubledayEVPSell1,666$79.27$132,063.82View SEC Filing  
10/20/2015Andrew K BaloEVPSell4,538$81.46$369,665.48View SEC Filing  
10/19/2015Jess RoperCFOSell7,000$83.37$583,590.00View SEC Filing  
10/15/2015Terrance H GreggChairmanSell15,000$77.92$1,168,800.00View SEC Filing  
10/6/2015Andrew K BaloEVPSell8,216$82.29$676,094.64View SEC Filing  
9/23/2015Steven Robert PacelliEVPSell14,000$98.08$1,373,120.00View SEC Filing  
9/21/2015Andrew K BaloEVPSell7,859$100.72$791,558.48View SEC Filing  
9/18/2015Jess RoperCFOSell7,000$101.22$708,540.00View SEC Filing  
9/15/2015Terrance H. GreggChairmanSell29,999$96.22$2,886,503.78View SEC Filing  
9/11/2015Terrance H. GreggChairmanSell47,500$96.50$4,583,750.00View SEC Filing  
9/10/2015Terrance H. GreggChairmanSell62,501$95.91$5,994,470.91View SEC Filing  
9/9/2015Jonathan T Md LordDirectorSell10,000$90.96$909,600.00View SEC Filing  
9/8/2015Andrew K BaloEVPSell7,500$89.53$671,475.00View SEC Filing  
9/8/2015John ListerVPSell2,642$89.36$236,089.12View SEC Filing  
9/8/2015Terrance H. GreggChairmanSell25,000$90.85$2,271,250.00View SEC Filing  
9/1/2015Jeffrey MoySVPSell8,881$90.61$804,707.41View SEC Filing  
9/1/2015Jorge A. ValdesinsiderSell20,000$91.22$1,824,400.00View SEC Filing  
8/28/2015Steven Robert PacelliEVPSell19,854$94.67$1,879,578.18View SEC Filing  
8/24/2015Steven Robert PacelliEVPSell14,000$84.18$1,178,520.00View SEC Filing  
8/20/2015Andrew K BaloEVPSell7,500$92.47$693,525.00View SEC Filing  
8/18/2015Steven R AltmanDirectorSell5,000$96.69$483,450.00View SEC Filing  
8/17/2015Jay S SkylerDirectorSell20,000$96.65$1,933,000.00View SEC Filing  
8/17/2015Terrance H GreggChairmanSell15,000$96.71$1,450,650.00View SEC Filing  
8/14/2015Kevin R SayerCEOSell35,000$97.41$3,409,350.00View SEC Filing  
7/23/2015Richard DoubledayEVPSell9,641$85.37$823,052.17View SEC Filing  
7/22/2015Andrew K BaloEVPSell10,214$84.78$865,942.92View SEC Filing  
7/21/2015Jeffrey MoySVPSell3,786$83.48$316,055.28View SEC Filing  
7/20/2015Jess RoperCFOSell7,000$83.74$586,180.00View SEC Filing  
7/17/2015Terrance H GreggChairmanSell50,750$83.07$4,215,802.50View SEC Filing  
7/15/2015Jay S SkylerDirectorSell20,000$81.69$1,633,800.00View SEC Filing  
7/8/2015Andrew K BaloEVPSell4,494$80.22$360,508.68View SEC Filing  
7/8/2015John ListerVPSell1,776$79.94$141,973.44View SEC Filing  
7/8/2015Jorge A ValdesInsiderSell50,000$79.83$3,991,500.00View SEC Filing  
7/7/2015Jeffrey MoySVPSell5,000$79.32$396,600.00View SEC Filing  
6/23/2015Jeffrey MoySVPSell5,154$77.54$399,641.16View SEC Filing  
6/23/2015Steven Robert PacelliEVPSell14,000$77.53$1,085,420.00View SEC Filing  
6/18/2015Jess RoperCFOSell7,000$77.10$539,700.00View SEC Filing  
6/15/2015Jay S SkylerDirectorSell20,000$70.67$1,413,400.00View SEC Filing  
6/15/2015Terrance H GreggChairmanSell15,000$70.94$1,064,100.00View SEC Filing  
6/12/2015Terrance H. GreggChairmanSell25,000$72.30$1,807,500.00View SEC Filing  
6/11/2015Jeffrey MoySVPSell9,869$73.00$720,437.00View SEC Filing  
6/9/2015Andrew K BaloEVPSell7,500$70.62$529,650.00View SEC Filing  
6/9/2015Jeffrey MoySVPSell5,000$70.63$353,150.00View SEC Filing  
6/9/2015Jorge A ValdesInsiderSell19,680$71.32$1,403,577.60View SEC Filing  
6/8/2015John ListerVPSell1,776$72.03$127,925.28View SEC Filing  
6/8/2015Jorge A ValdesInsiderSell8,243$72.07$594,073.01View SEC Filing  
6/3/2015Terrance H GreggChairmanSell40,000$72.77$2,910,800.00View SEC Filing  
6/2/2015Terrance H GreggChairmanSell5,000$73.12$365,600.00View SEC Filing  
6/1/2015Terrance H GreggChairmanSell10,000$72.75$727,500.00View SEC Filing  
5/27/2015Jeffrey MoySVPSell21,791$69.60$1,516,653.60View SEC Filing  
5/27/2015Richard DoubledayEVPSell3,258$70.73$230,438.34View SEC Filing  
5/18/2015Andrew K BaloEVPSell7,500$68.46$513,450.00View SEC Filing  
5/18/2015Jeffrey MoySVPSell15,586$69.20$1,078,551.20View SEC Filing  
5/18/2015Jess RoperCFOSell7,000$69.27$484,890.00View SEC Filing  
5/15/2015Terrance H GreggChairmanSell82,500$69.24$5,712,300.00View SEC Filing  
5/12/2015Jeffrey MoySVPSell20,303$67.84$1,377,355.52View SEC Filing  
5/12/2015Jorge A ValdesInsiderSell30,878$68.27$2,108,041.06View SEC Filing  
5/11/2015Jeffrey MoySVPSell15,303$68.25$1,044,429.75View SEC Filing  
5/11/2015Terrance H GreggChairmanSell3,517$68.65$241,442.05View SEC Filing  
5/8/2015Terrance H GreggChairmanSell91,483$67.85$6,207,121.55View SEC Filing  
5/4/2015Kevin R SayerCEOSell25,000$68.01$1,700,250.00View SEC Filing  
4/28/2015Jeffrey MoySVPSell10,000$68.41$684,100.00View SEC Filing  
4/27/2015Jeffrey MoySVPSell5,000$69.27$346,350.00View SEC Filing  
4/23/2015Steven Robert PacelliEVPSell39,709$69.63$2,764,937.67View SEC Filing  
4/20/2015Jess RoperCFOSell7,000$68.05$476,350.00View SEC Filing  
4/15/2015Terrance H GreggChairmanSell15,000$67.56$1,013,400.00View SEC Filing  
4/14/2015Jeffrey MoySVPSell20,766$66.63$1,383,638.58View SEC Filing  
4/9/2015Andrew K BaloEVPSell7,500$64.55$484,125.00View SEC Filing  
4/9/2015Jorge A ValdesInsiderSell19,684$64.38$1,267,255.92View SEC Filing  
4/8/2015John ListerVPSell5,039$63.84$321,689.76View SEC Filing  
3/25/2015Andrew K BaloEVPSell7,500$61.05$457,875.00View SEC Filing  
3/23/2015Steven Robert PacelliEVPSell14,000$61.33$858,620.00View SEC Filing  
3/18/2015Jess RoperCFOSell7,000$62.43$437,010.00View SEC Filing  
3/17/2015Terrance H GreggChairmanSell15,000$62.82$942,300.00View SEC Filing  
3/13/2015Jay S SkylerDirectorSell45,000$60.01$2,700,450.00View SEC Filing  
3/12/2015Jorge A ValdesInsiderSell11,138$59.78$665,829.64View SEC Filing  
3/12/2015Richard DoubledayEVPSell20,000$59.23$1,184,600.00View SEC Filing  
3/9/2015John ListerVPSell5,039$58.77$296,142.03View SEC Filing  
3/9/2015Jorge A ValdesInsiderSell8,244$58.77$484,499.88View SEC Filing  
2/23/2015Richard DoubledayEVPSell4,000$63.58$254,320.00View SEC Filing  
2/9/2015John ListerVPSell5,039$61.66$310,704.74View SEC Filing  
2/9/2015Jorge A ValdesInsiderSell8,244$61.67$508,407.48View SEC Filing  
2/2/2015Jeffrey MoySVPSell5,000$60.69$303,450.00View SEC Filing  
1/26/2015Steven Robert PacelliEVPSell24,532$59.67$1,463,824.44View SEC Filing  
1/23/2015Richard DoubledayEVPSell4,000$58.22$232,880.00View SEC Filing  
1/20/2015Jeffrey MoySVPSell5,000$57.58$287,900.00View SEC Filing  
1/20/2015Jess RoperCFOSell7,000$57.34$401,380.00View SEC Filing  
1/15/2015Terrance H GreggChairmanSell15,000$57.84$867,600.00View SEC Filing  
1/13/2015Steven Robert PacelliEVPSell9,468$62.22$589,098.96View SEC Filing  
1/12/2015Steven Robert PacelliEVPSell20,000$59.18$1,183,600.00View SEC Filing  
1/9/2015Jorge A ValdesInsiderSell9,170$57.55$527,733.50View SEC Filing  
1/8/2015John ListerVPSell5,039$57.42$289,339.38View SEC Filing  
1/5/2015Jeffrey MoySVPSell5,000$55.27$276,350.00View SEC Filing  
12/26/2014Andrew K BaloSVPSell10,000$55.27$552,700.00View SEC Filing  
12/23/2014Richard DoubledayVPSell4,000$54.69$218,760.00View SEC Filing  
12/23/2014Steven Robert PacelliEVPSell14,000$54.62$764,680.00View SEC Filing  
12/18/2014Jess RoperCFOSell12,000$56.43$677,160.00View SEC Filing  
12/15/2014Terrance H GreggCEOSell35,000$53.23$1,863,050.00View SEC Filing  
12/8/2014Jorge A ValdesInsiderSell16,000$56.03$896,480.00View SEC Filing  
12/3/2014Eric TopolDirectorSell20,000$55.00$1,100,000.00View SEC Filing  
11/28/2014Terrance H GreggCEOSell59,990$51.51$3,090,084.90View SEC Filing  
11/25/2014Andrew K BaloSVPSell10,000$51.11$511,100.00View SEC Filing  
11/25/2014Terrance H GreggCEOSell55,010$51.04$2,807,710.40View SEC Filing  
11/24/2014Richard DoubledayVPSell4,000$50.36$201,440.00View SEC Filing  
11/24/2014Terrance H GreggCEOSell35,000$51.06$1,787,100.00View SEC Filing  
11/21/2014Terrance H GreggCEOSell10,000$50.50$505,000.00View SEC Filing  
11/19/2014Terrance H GreggCEOSell10,000$51.00$510,000.00View SEC Filing  
11/17/2014Terrance H GreggCEOSell45,000$52.52$2,363,400.00View SEC Filing  
11/12/2014Terrance H GreggCEOSell80,000$53.36$4,268,800.00View SEC Filing  
11/10/2014Jorge A ValdesInsiderSell16,000$51.23$819,680.00View SEC Filing  
10/27/2014Andrew K BaloSVPSell10,000$42.98$429,800.00View SEC Filing  
10/23/2014Richard DoubledayVPSell4,000$43.58$174,320.00View SEC Filing  
10/23/2014Steven Robert PacelliEVPSell14,000$43.60$610,400.00View SEC Filing  
10/13/2014Andrew K BaloSVPSell10,000$40.42$404,200.00View SEC Filing  
10/13/2014John ListerVPSell3,400$40.41$137,394.00View SEC Filing  
10/8/2014Jorge A ValdesInsiderSell16,000$40.29$644,640.00View SEC Filing  
9/25/2014Andrew K BaloSVPSell10,000$40.71$407,100.00View SEC Filing  
9/23/2014Richard DoubledayVPSell4,000$40.32$161,280.00View SEC Filing  
9/23/2014Steven Robert PacelliEVPSell14,000$40.32$564,480.00View SEC Filing  
9/18/2014Jess RoperCFOSell8,000$41.91$335,280.00View SEC Filing  
9/15/2014Terrance H GreggCEOSell35,000$41.14$1,439,900.00View SEC Filing  
9/12/2014John ListerVPSell3,518$43.70$153,736.60View SEC Filing  
9/11/2014Andrew K BaloSVPSell10,000$42.97$429,700.00View SEC Filing  
9/8/2014Jorge A ValdesInsiderSell16,000$42.98$687,680.00View SEC Filing  
8/28/2014Barbara KahnDirectorSell4,000$44.52$178,080.00View SEC Filing  
8/26/2014Jeffrey MoySVPSell16,663$45.30$754,833.90View SEC Filing  
8/26/2014Jonathan T Md LordDirectorSell20,000$45.56$911,200.00View SEC Filing  
8/26/2014Steven Robert PacelliEVPSell30,000$44.56$1,336,800.00View SEC Filing  
8/26/2014Terrance H GreggCEOSell5,000$46.05$230,250.00View SEC Filing  
8/25/2014Andrew K BaloSVPSell10,000$44.12$441,200.00View SEC Filing  
8/25/2014Richard DoubledayVPSell4,000$44.35$177,400.00View SEC Filing  
8/25/2014Steven Robert PacelliEVPSell14,000$44.24$619,360.00View SEC Filing  
8/22/2014Andrew K BaloSVPSell20,000$44.24$884,800.00View SEC Filing  
8/22/2014Terrance H GreggCEOSell13,607$44.46$604,967.22View SEC Filing  
8/21/2014Barbara KahnDirectorSell2,200$43.42$95,524.00View SEC Filing  
8/21/2014Jorge A ValdesInsiderSell10,671$43.58$465,042.18View SEC Filing  
8/21/2014Terrance H GreggCEOSell23,893$44.36$1,059,893.48View SEC Filing  
8/19/2014Richard DoubledayVPSell20,000$45.01$900,200.00View SEC Filing  
8/19/2014Terrance H GreggCEOSell75,000$45.08$3,381,000.00View SEC Filing  
8/18/2014Terrance H GreggCEOSell65,000$44.16$2,870,400.00View SEC Filing  
8/14/2014Terrance H GreggCEOSell25,000$44.24$1,106,000.00View SEC Filing  
8/13/2014Terrance H GreggCEOSell56,107$43.57$2,444,581.99View SEC Filing  
8/11/2014Andrew K BaloSVPSell10,000$44.24$442,400.00View SEC Filing  
8/11/2014Kevin R SayerCOOSell20,000$43.82$876,400.00View SEC Filing  
8/8/2014Jorge A ValdesInsiderSell16,000$43.56$696,960.00View SEC Filing  
7/25/2014Andrew K BaloSVPSell10,000$38.19$381,900.00View SEC Filing  
7/23/2014Richard DoubledayVPSell4,000$38.16$152,640.00View SEC Filing  
7/23/2014Steven Robert PacelliEVPSell14,000$38.28$535,920.00View SEC Filing  
7/18/2014Jess RoperCFOSell8,000$36.01$288,080.00View SEC Filing  
7/15/2014Terrance H GreggCEOSell35,000$36.66$1,283,100.00View SEC Filing  
7/14/2014John ListerVPSell3,500$36.59$128,065.00View SEC Filing  
7/11/2014Andrew K BaloSVPSell10,000$35.93$359,300.00View SEC Filing  
7/8/2014Jorge A ValdesInsiderSell16,000$36.66$586,560.00View SEC Filing  
7/2/2014Jay S SkylerDirectorSell30,000$40.05$1,201,500.00View SEC Filing  
6/25/2014Andrew K BaloSVPSell10,000$40.60$406,000.00View SEC Filing  
6/23/2014Richard DoubledayVPSell4,000$40.98$163,920.00View SEC Filing  
6/23/2014Steven Robert PacelliEVPSell14,000$41.02$574,280.00View SEC Filing  
6/20/2014Jay S SkylerDirectorSell60,000$40.00$2,400,000.00View SEC Filing  
6/18/2014Jess RoperCFOSell8,000$39.17$313,360.00View SEC Filing  
6/16/2014Terrance H GreggCEOSell35,000$37.23$1,303,050.00View SEC Filing  
6/12/2014John ListerVPSell3,500$36.13$126,455.00View SEC Filing  
6/11/2014Andrew K BaloSVPSell10,000$36.63$366,300.00View SEC Filing  
6/9/2014Jorge A ValdesInsiderSell16,000$36.68$586,880.00View SEC Filing  
6/5/2014Richard DoubledayVPSell4,000$35.59$142,360.00View SEC Filing  
5/27/2014Andrew K BaloSVPSell10,000$33.86$338,600.00View SEC Filing  
5/19/2014Jess RoperCFOSell8,000$32.20$257,600.00View SEC Filing  
5/8/2014Jorge ValdesInsiderSell16,000$29.83$477,280.00View SEC Filing  
4/25/2014Andrew BaloSVPSell10,000$34.35$343,500.00View SEC Filing  
4/23/2014Richard DoubledayVPSell4,000$35.92$143,680.00View SEC Filing  
4/23/2014Steven Robert PacelliEVPSell14,000$35.90$502,600.00View SEC Filing  
4/21/2014Jess RoperCFOSell8,000$36.18$289,440.00View SEC Filing  
4/15/2014Terrance GreggCEOSell35,000$34.09$1,193,150.00View SEC Filing  
4/14/2014John ListerVPSell2,884$35.86$103,420.24View SEC Filing  
4/11/2014Andrew BaloSVPSell10,000$35.36$353,600.00View SEC Filing  
4/8/2014Jorge ValdesInsiderSell16,000$35.99$575,840.00View SEC Filing  
3/26/2014Jay SkylerDirectorSell30,000$43.05$1,291,500.00View SEC Filing  
3/25/2014Andrew BaloSVPSell10,000$43.00$430,000.00View SEC Filing  
3/24/2014Steven Robert PacelliEVPSell14,000$42.92$600,880.00View SEC Filing  
3/18/2014Jess RoperCFOSell8,000$46.00$368,000.00View SEC Filing  
3/17/2014Terrance GreggCEOSell45,000$45.25$2,036,250.00View SEC Filing  
3/12/2014Terrance GreggCEOSell30,000$45.50$1,365,000.00View SEC Filing  
3/10/2014Jorge ValdesInsiderSell16,000$46.57$745,120.00View SEC Filing  
3/5/2014Jeffrey MoySVPSell10,000$47.30$473,000.00View SEC Filing  
3/5/2014Terrance GreggCEOSell111,890$47.46$5,310,299.40View SEC Filing  
3/3/2014Terrance GreggCEOSell40,000$44.87$1,794,800.00View SEC Filing  
2/26/2014Jess RoperCFOSell25,000$45.20$1,130,000.00View SEC Filing  
2/25/2014Steven Robert PacelliEVPSell33,368$44.93$1,499,224.24View SEC Filing  
1/23/2014Steven Robert PacelliEVPSell14,000$36.49$510,860.00View SEC Filing  
1/21/2014Jess RoperCFOSell8,000$37.38$299,040.00View SEC Filing  
12/18/2013Jess RoperCFOSell8,000$34.48$275,840.00View SEC Filing  
12/13/2013Terrance GreggCEOSell50,000$34.41$1,720,500.00View SEC Filing  
12/12/2013Nicholas AugustinosDirectorSell11,321$34.40$389,442.40View SEC Filing  
12/10/2013Nicholas AugustinosDirectorSell97,541$33.64$3,281,279.24View SEC Filing  
12/5/2013Terrance GreggCEOSell20,000$34.77$695,400.00View SEC Filing  
12/3/2013Andrew BaloSVPSell14,268$34.21$488,108.28View SEC Filing  
11/15/2013Terrance GreggCEOSell35,000$32.74$1,145,900.00View SEC Filing  
9/3/2013Terrance GreggCEOSell9,000$27.00$243,000.00View SEC Filing  
8/1/2013Terrance H GreggCEOSell9,000$22.15$199,350.00View SEC Filing  
7/1/2013Terrance H GreggCEOSell9,000$22.87$205,830.00View SEC Filing  
6/13/2013Andrew K BaloSVPSell10,000$21.90$219,000.00View SEC Filing  
6/11/2013Jess RoperCFOSell10,361$22.33$231,361.13View SEC Filing  
6/11/2013John ListerVPSell2,000$22.43$44,860.00View SEC Filing  
6/11/2013Steven Robert PacelliEVPSell5,000$22.31$111,550.00View SEC Filing  
6/4/2013Terrance H GreggCEOSell19,000$21.32$405,080.00View SEC Filing  
5/15/2013Jeffrey MoySVPSell5,000$19.97$99,850.00View SEC Filing  
5/13/2013Andrew K BaloSVPSell45,000$19.40$873,000.00View SEC Filing  
5/9/2013Richard DoubledaySVPSell1,272$19.56$24,880.32View SEC Filing  
3/13/2013Andrew K BaloSVPSell15,416$16.53$254,826.48View SEC Filing  
3/11/2013Jay S SkylerDirectorBuy70,000$15.50$1,085,000.00View SEC Filing  
3/11/2013John ListerVPSell4,500$15.75$70,875.00View SEC Filing  
3/11/2013Richard DoubledaySVPSell5,100$15.63$79,713.00View SEC Filing  
2/1/2013Terrance H GreggCEOSell9,000$15.08$135,720.00View SEC Filing  
12/3/2012Terrance H GreggCEOSell5,000$13.24$66,200.00View SEC Filing  
9/4/2012Terrance H GreggCEOSell15,000$13.46$201,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for DexCom (NASDAQ:DXCM)
Latest Headlines for DexCom (NASDAQ:DXCM)
Source:
DateHeadline
americanbankingnews.com logoDexCom, Inc. (DXCM) EVP Sells $100,731.50 in Stock
www.americanbankingnews.com - July 25 at 10:21 PM
americanbankingnews.com logoDexCom, Inc. (NASDAQ:DXCM) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - July 25 at 8:02 AM
finance.yahoo.com logoETFs with exposure to DexCom, Inc. : July 24, 2017
finance.yahoo.com - July 24 at 5:51 PM
americanbankingnews.com logoDexCom, Inc. (DXCM) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 24 at 9:36 AM
finance.yahoo.com logoDexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : July 17, 2017
finance.yahoo.com - July 17 at 11:22 AM
americanbankingnews.com logoDexCom, Inc. (NASDAQ:DXCM) Stock Rating Reaffirmed by Cowen and Company
www.americanbankingnews.com - July 15 at 8:06 AM
finance.yahoo.com logoETFs with exposure to DexCom, Inc. : July 14, 2017
finance.yahoo.com - July 14 at 4:06 PM
americanbankingnews.com logoBMO Capital Markets Reaffirms "Buy" Rating for DexCom, Inc. (NASDAQ:DXCM)
www.americanbankingnews.com - July 13 at 9:40 PM
americanbankingnews.com logoDexCom, Inc. (NASDAQ:DXCM) Expected to Announce Quarterly Sales of $166.23 Million
www.americanbankingnews.com - July 13 at 1:25 PM
americanbankingnews.com logoInsider Selling: DexCom, Inc. (NASDAQ:DXCM) CEO Sells 6,000 Shares of Stock
www.americanbankingnews.com - July 12 at 8:18 PM
americanbankingnews.com logoDexCom, Inc. (NASDAQ:DXCM) EVP Andrew K. Balo Sells 3,200 Shares
www.americanbankingnews.com - July 12 at 8:16 PM
americanbankingnews.com logoDexCom, Inc. (NASDAQ:DXCM) Given "Buy" Rating at Piper Jaffray Companies
www.americanbankingnews.com - July 12 at 7:56 AM
americanbankingnews.com logo-$0.22 EPS Expected for DexCom, Inc. (DXCM) This Quarter
www.americanbankingnews.com - July 11 at 8:56 AM
seekingalpha.com logoThe Future Of Dexcom - Seeking Alpha
seekingalpha.com - July 6 at 2:30 AM
americanbankingnews.com logoDexCom, Inc. (DXCM) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - July 5 at 11:06 PM
finance.yahoo.com logoDexCom, Inc. – Value Analysis (NASDAQ:DXCM) : July 5, 2017
finance.yahoo.com - July 5 at 6:45 PM
finance.yahoo.com logoDexCom, Inc. breached its 50 day moving average in a Bearish Manner : DXCM-US : July 4, 2017
finance.yahoo.com - July 4 at 3:51 PM
americanbankingnews.com logoDexCom, Inc. (DXCM) EVP Sells $113,375.50 in Stock
www.americanbankingnews.com - June 27 at 7:51 PM
americanbankingnews.com logoDexCom, Inc. (DXCM) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 27 at 8:21 AM
americanbankingnews.com logoDexCom, Inc. (DXCM) Upgraded to "Buy" at BidaskClub
www.americanbankingnews.com - June 21 at 7:32 PM
finance.yahoo.com logoDexCom Schedules Second Quarter 2017 Earnings Release and Conference Call for August 1, 2017 at 4:30 p.m. Eastern Time
finance.yahoo.com - June 20 at 5:34 PM
americanbankingnews.com logo$166.10 Million in Sales Expected for DexCom, Inc. (DXCM) This Quarter
www.americanbankingnews.com - June 17 at 11:02 AM
americanbankingnews.com logoDexCom, Inc. (DXCM) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 15 at 6:58 PM
americanbankingnews.com logo-$0.21 Earnings Per Share Expected for DexCom, Inc. (DXCM) This Quarter
www.americanbankingnews.com - June 15 at 8:04 AM
americanbankingnews.com logoKevin R. Sayer Sells 6,000 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - June 13 at 10:32 PM
americanbankingnews.com logoAndrew K. Balo Sells 3,200 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - June 13 at 8:15 PM
streetinsider.com logoDexCom (DXCM) to Present New Data on Adults with Type 1 & Type 2 Diabetes on Multiple Daily Injections - StreetInsider.com
www.streetinsider.com - June 10 at 4:59 PM
streetinsider.com logoDexCom (DXCM) Announces Addition of Ambulatory Glucose Profile to Dexcom CLARITY - StreetInsider.com
www.streetinsider.com - June 10 at 4:59 PM
americanbankingnews.com logoComparing Rosetta Genomics (ROSG) & DexCom (DXCM)
www.americanbankingnews.com - June 10 at 7:40 AM
finance.yahoo.com logoNew Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections (MDI) Benefit from CGM
finance.yahoo.com - June 9 at 10:10 AM
streetinsider.com logoDexCom (DXCM) Says FDA Approves G5 Mobile App for Android
www.streetinsider.com - June 8 at 5:52 PM
finance.yahoo.com logoDexcom to Add Ambulatory Glucose Profile (AGP) to Dexcom CLARITY®
finance.yahoo.com - June 8 at 5:52 PM
streetinsider.com logoDexCom (DXCM) Says FDA Approves G5 Mobile App for Android - StreetInsider.com
www.streetinsider.com - June 8 at 2:48 AM
finance.yahoo.com logoDexCom Announces FDA Approval of G5 Mobile App for Android Devices
finance.yahoo.com - June 8 at 2:48 AM
finance.yahoo.com logoDexCom wins FDA approval for G5 mobile app for android devices
finance.yahoo.com - June 8 at 2:48 AM
finance.yahoo.com logoDexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices
finance.yahoo.com - June 8 at 2:48 AM
americanbankingnews.com logoDexCom, Inc. (DXCM) Earns Buy Rating from Canaccord Genuity
www.americanbankingnews.com - June 7 at 8:20 AM
finance.yahoo.com logoStrength Seen in DexCom (DXCM): Stock Adds 5% in Session
finance.yahoo.com - June 6 at 5:12 PM
finance.yahoo.com logoCompany News for June 06, 2017
finance.yahoo.com - June 6 at 5:12 PM
finance.yahoo.com logoDexCom shares jump nearly 4% on Tim Cook's comments on glucose monitors at Apple event
finance.yahoo.com - June 5 at 4:52 PM
finance.yahoo.com logoApple Watch to allow glucose data pulling from Dexcom
finance.yahoo.com - June 5 at 4:52 PM
finance.yahoo.com logoThe Apple Watch is about to get a lot more useful with swappable bands to track health symptoms
finance.yahoo.com - June 5 at 4:52 PM
finance.yahoo.com logoDexCom Stock Surging on Apple Watch Partnership
finance.yahoo.com - June 5 at 4:52 PM
finance.yahoo.com logoDexCom (DXCM) Stock Rallies on Apple Watch Partnership
finance.yahoo.com - June 5 at 4:52 PM
nasdaq.com logoDexCom (DXCM) Down 9.6% Since Earnings Report: Can It Rebound? - Nasdaq
www.nasdaq.com - June 4 at 4:57 PM
finance.yahoo.com logoDexCom (DXCM) Down 9.6% Since Earnings Report: Can It Rebound?
finance.yahoo.com - June 2 at 4:16 PM
americanbankingnews.com logoDexCom, Inc. (DXCM) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 31 at 9:22 AM
seekingalpha.com logoDexcom's Implantable Blood Sugar Monitor Sales Rise - Seeking Alpha
seekingalpha.com - May 30 at 9:45 PM
finance.yahoo.com logoPost Earnings Coverage as Charles River Laboratories' Revenue Surged 25.6%, non-GAAP EPS Jumped 32%
finance.yahoo.com - May 30 at 11:36 AM
finance.yahoo.com logoETFs with exposure to DexCom, Inc. : May 29, 2017
finance.yahoo.com - May 29 at 4:54 PM

Social

Chart

DexCom (DXCM) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff